Renin FRET Substrate I de E InChi: InChI=1S/C41H42N10O6/c1-5-51-32(18-28(48-51)23-11-12-23)44-37-35-25-17-31(56-4)26(34-20(2)49-57-21(34)3)16-29(25)43-36(35)46-38(47-37)40(54)42-15-7-9-22-8-6-10-24-27(22)19-50(41(24)55)30-13-14-33(52)45-39(30)53/h6

InChi: InChI=1S/C41H42N10O6/c1-5-51-32(18-28(48-51)23-11-12-23)44-37-35-25-17-31(56-4)26(34-20(2)49-57-21(34)3)16-29(25)43-36(35)46-38(47-37)40(54)42-15-7-9-22-8-6-10-24-27(22)19-50(41(24)55)30-13-14-33(52)45-39(30)53/h6

Pico145 potently inhibits RPC4-TRPC1 channels activated by sphingosine 1-phosphate (S1P)

(E)-2-Decenoic acid and 10-hydroxy-trans-2-decenoic acid are both described to demonstrate estrogenic activity

Smiles: C#CCOCCOCCOCC#C

a derivative of Nobiletin

Renin FRET Substrate I de E InChi: InChI=1S/C41H42N10O6/c1-5-51-32(18-28(48-51)23-11-12-23)44-37-35-25-17-31(56-4)26(34-20(2)49-57-21(34)3)16-29(25)43-36(35)46-38(47-37)40(54)42-15-7-9-22-8-6-10-24-27(22)19-50(41(24)55)30-13-14-33(52)45-39(30)53/h6Renin FRET Substrate I is a substrate of human renin. Renin FRET Substrate I is designed to incorporate the renin cleavage site that occurs in the N terminal peptide of human angiotensinogen. Product information CAS Number: 142988 22 5 Molecular Weight: 1876. 23 Formula: C96H126N22O16S Chemical Name: 5 ({2 [(2S,3R) 2 [(2S) 2 [(2S,3S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 {[(2S) 1 [(2S) 2 [(2S,3S) 2 {4 [(4 {2 [4 (dimethylamino)phenyl]diazen 1